Skip to content
Search

Latest Stories

The Truth About Measles

Morbillivirus measles infection.jpg - Wikipedia

Conditions & Symptoms

Cracking the Code of Dravet Syndrome: New Hope with Breakthrough Treatments

Cracking the Code of Dravet Syndrome: New Hope with Breakthrough Treatments

Dravet syndrome is a rare and severe form of epilepsy that begins in infancy, characterized by prolonged seizures, developmental delays, and a significantly impaired quality of life. This condition is particularly challenging to manage, with many patients experiencing drug-resistant seizures. However, recent advancements in the understanding and treatment of Dravet syndrome have brought hope to patients and families affected by this debilitating disorder.

What Is Dravet Syndrome?


Dravet syndrome, also known as severe myoclonic epilepsy of infancy (SMEI), typically begins within the first year of life, often triggered by fever-related seizures. The syndrome is caused by mutations in the SCN1A gene, which encodes a sodium channel critical for normal brain function. These mutations lead to hyperexcitability of neurons, resulting in frequent and severe seizures.

Patients with Dravet syndrome often experience a variety of seizure types, including generalized tonic-clonic, myoclonic, and absence seizures. As the disorder progresses, children may also develop cognitive impairments, motor difficulties, and behavioral issues. Additionally, they are at increased risk of sudden unexpected death in epilepsy (SUDEP), making effective treatment even more critical.

Challenges in Treatment

Dravet syndrome is notoriously difficult to treat. Many patients do not respond well to standard anti-epileptic drugs (AEDs), and some medications can even exacerbate seizures. The goal of treatment is to reduce seizure frequency and severity, improve quality of life, and minimize the risk of SUDEP. However, until recently, treatment options were limited and often insufficient in controlling the disorder's symptoms.

New Treatments and Breakthroughs

Recent years have seen significant advancements in the treatment of Dravet syndrome, with new therapies offering hope where traditional medications have failed. Here are some of the most promising developments:

  1. Cannabidiol (CBD) - Epidiolex: One of the most significant breakthroughs in the treatment of Dravet syndrome is the approval of Epidiolex, a purified form of cannabidiol (CBD). Epidiolex was the first FDA-approved drug derived from cannabis and has shown to be effective in reducing seizure frequency in patients with Dravet syndrome. Clinical trials demonstrated that patients taking Epidiolex experienced a significant reduction in seizure frequency compared to those taking a placebo, with some achieving a reduction of 50% or more . Importantly, Epidiolex has been shown to be effective without the psychoactive effects associated with THC, the other primary component of cannabis.
  2. Fenfluramine (Fintepla): Fintepla is another recent FDA-approved treatment for Dravet syndrome. Originally used as an appetite suppressant, fenfluramine was found to have strong anti-seizure properties. In clinical trials, Fintepla significantly reduced the frequency of convulsive seizures in patients with Dravet syndrome, with some patients experiencing a 75% or greater reduction . Despite concerns about its previous association with heart valve issues, the drug has been reformulated and is carefully monitored to mitigate these risks.
  3. Stiripentol (Diacomit): Stiripentol is a newer AED that has shown effectiveness when used in combination with clobazam and valproate. It enhances the effects of these medications, leading to better seizure control in some patients with Dravet syndrome. Stiripentol was approved by the FDA for the treatment of Dravet syndrome in 2018, providing another option for those who have not responded well to other treatments.
  4. Gene Therapy and SCN1A Modulation: As Dravet syndrome is often caused by mutations in the SCN1A gene, research into gene therapy offers a potential cure. Scientists are exploring ways to correct or compensate for the defective gene. One promising approach is the use of antisense oligonucleotides (ASOs), which are short DNA or RNA sequences that can bind to RNA transcripts and modulate gene expression. Early studies in animal models have shown that this approach can reduce seizures and improve neurological function .
  5. Soticlestat: Soticlestat is an investigational drug that targets the cholesterol biosynthesis pathway, which has been implicated in seizure disorders. Early clinical trials have shown that Soticlestat can reduce seizure frequency in patients with Dravet syndrome. While still in the experimental stage, it represents another promising avenue for treatment .

The Future of Dravet Syndrome Treatment

The advancements in Dravet syndrome treatment over the past few years have been remarkable, offering new hope to patients and their families. However, the search for more effective treatments continues. Researchers are actively exploring novel therapies, including additional gene therapy approaches, new drug targets, and personalized medicine strategies tailored to the genetic profile of each patient.

Dravet syndrome remains a challenging condition to manage, but the recent approval of new treatments such as Epidiolex, Fintepla, and Stiripentol, along with ongoing research into gene therapy and other novel approaches, marks a new era in the fight against this debilitating disorder. As research progresses, the future holds promise for even more effective treatments, bringing hope to those affected by Dravet syndrome and their families.

References:

  1. Devinsky, O., Cross, J.H., Laux, L., et al. (2017). Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome. New England Journal of Medicine, 376(21), 2011-2020. doi:10.1056/NEJMoa1611618
  2. Nabbout, R., Mistry, A., Zuberi, S., et al. (2020). Fenfluramine for Treatment-Resistant Seizures in Dravet Syndrome: A Multicenter, Randomized, Double-blind, Placebo-Controlled Trial. Lancet, 394(10212), 2243-2254. doi:10.1016/S0140-6736(19)32500-0
  3. Lagae, L., Brambilla, I., Mingorance, A., et al. (2018). Dravet Syndrome: A European Perspective. Epilepsy & Behavior, 91, 99-110. doi:10.1016/j.yebeh.2018.12.010
  4. Huguenard, J.R., & McCormick, D.A. (2007). Thalamic Synchrony and Dynamic Regulation of Global Forebrain Oscillations. Trends in Neurosciences, 30(7), 350-356. doi:10.1016/j.tins.2007.05.007
  5. Lenk, G.M., & Meisler, M.H. (2021). SCN1A and Dravet Syndrome: Mutations, Mechanisms, and Antisense Oligonucleotide Therapy. Epilepsia Open, 6(3), 384-393. doi:10.1002/epi4.12508

More Stories

Tuberculosis Outbreak in Kansas: A Warning for the Nation
Photo by Josh Redd on Unsplash

Tuberculosis Outbreak in Kansas: A Warning for the Nation

A recent tuberculosis outbreak in Kansas has raised alarms among health officials, highlighting the persistent dangers of this infectious disease and its potential implications for the rest of the United States. The outbreak, primarily affecting Wyandotte and Johnson counties, is one of the largest recorded in U.S. history, with 67 active cases and 79 latent infections as of January 2025 (AP News). What does this mean for the rest of the country?

The Scope of the Outbreak

The outbreak has resulted in two confirmed fatalities in 2024, prompting a swift response from the Kansas Department of Health and Environment (KDHE) and the Centers for Disease Control and Prevention (CDC). The agencies have ramped up contact tracing, testing, and treatment efforts to contain the disease. Despite these efforts, the outbreak serves as a stark reminder of the challenges associated with TB control (AP News).

Keep ReadingShow less
Cortisol Levels: Should You Lower Them and Do Detox Diets Work?
Photo by JESHOOTS.COM on Unsplash

Cortisol Levels: Should You Lower Them and Do Detox Diets Work?

Recently, Cortisol has become the "in" thing. It's everywhere. Influencers and celebrities talk about it, there are supplements to "control" your Cortisol levels, there are detox diets, and more. So what is this all about? Cortisol, often called the "stress hormone," plays a pivotal role in the body. Produced by the adrenal glands, it helps regulate metabolism, blood sugar levels, immune responses, and the body’s stress reactions. However, modern lifestyles, marked by chronic stress, poor sleep, and unhealthy diets, can lead to imbalances in cortisol levels—either too high or too low. Is lowering cortisol is necessary? How it can be achieved? And do so-called "cortisol detox diets" have scientific backing?

What Are Cortisol Levels?

Cortisol levels naturally follow a diurnal rhythm (a daily cycle of physiological events that occur approximately once each day, synchronized to environmental cues but not driven by them). They are highest in the morning to help you wake up and gradually decline throughout the day, reaching their lowest point at night to prepare your body for rest.

Keep ReadingShow less
6 Simple Steps Women Can Take to Lower Heart Disease Risk—No Pills Needed

6 Simple Steps Women Can Take to Lower Heart Disease Risk—No Pills Needed

Scope of the problem

Heart disease is largely preventable, yet, it remains the number 1 cause of death in women in the United States, claiming the lives of 1 in 3 women, more than breast cancer (1 in 25 to 30 women die of breast cancer) and more than all cancers combined. Unfortunately, these statistics haven’t changed much over time. Despite all the sophisticated advances in cardiovascular care, women under 65 years old are twice as likely as their male counterparts to die following a heart attack.

Keep ReadingShow less
Male Menopause: Fact or Fiction

Male Menopause: Fact or Fiction

As a family physician and wellness advocate, I often encounter questions about whether “male menopause” is a real phenomenon. While aging related hormone changes in men are a reality, they differ significantly from the changes women experience during menopause. Let’s unpack the facts, debunk myths, and explore the signs, symptoms, and treatment options for age related hormonal changes in men.

Hormonal Changes: A Natural Part of Aging

Keep ReadingShow less

Pancreatic Cancer: The Legacy of Patrick Swayze and the Fight for Better Treatments

What 80's kid didn't love Patrick Swayze? Johnny Castle, Bohdi, James Dalton, Vida Boheme, and pancreatic cancer patient. Less than two years after he was diagnosed, Patrick Swayze died. Pancreatic cancer is one of the most aggressive and challenging cancers to diagnose and treat, earning a reputation as one of the deadliest forms of cancer. Despite accounting for only about 3% of all cancers in the U.S., it ranks as the fourth leading cause of cancer-related deaths. Its high mortality rate makes it crucial to understand the factors behind its severity and the advancements being made to combat it 【1】【2】.

Why Is Pancreatic Cancer So Deadly?

  1. Late Diagnosis
    Pancreatic cancer is often referred to as a "silent killer" because symptoms usually appear only in advanced stages. Common signs, such as abdominal pain, jaundice, and weight loss, often overlap with other conditions, delaying diagnosis. By the time pancreatic cancer is detected, it has often spread to other organs, making treatment more difficult 【2】【3】.
  2. Aggressive Nature
    Pancreatic tumors are highly invasive and have a unique ability to metastasize quickly. The cancer often spreads to the liver, lungs, or surrounding blood vessels, further limiting treatment options 【3】.
  3. Resistance to Treatment
    Unlike some cancers that respond well to chemotherapy or radiation, pancreatic cancer is often resistant to these therapies. Its dense tissue environment, called the tumor microenvironment, acts as a barrier, protecting cancer cells from treatment 【4】.
  4. Genetic Complexity
    Pancreatic cancer exhibits numerous genetic mutations, which complicates the development of targeted therapies. This genetic diversity makes it challenging to identify universal treatment strategies 【5】.
  5. Low Survival Rates
    The five-year survival rate for pancreatic cancer is just 12%, one of the lowest among major cancers. However, early detection can significantly improve outcomes, with localized cases having a five-year survival rate of around 44% 【1】.

What Is Being Done to Improve Treatment?

Despite its challenges, significant progress is being made in pancreatic cancer research and treatment:

Keep ReadingShow less
×